|
EXP001340
|
Improved cell-penetrating peptide–PNA conjugates for splicing redirection in He…
|
2008 |
Pip2a–PNADMD
|
PNA (steric-blocking)
|
no |
|
|
yes |
yes |
|
EXP001341
|
Improved cell-penetrating peptide–PNA conjugates for splicing redirection in He…
|
2008 |
Pip2b–PNADMD
|
PNA (steric-blocking)
|
no |
|
|
yes |
yes |
|
EXP001342
|
Improved cell-penetrating peptide–PNA conjugates for splicing redirection in He…
|
2008 |
RXR4–PNADMD
|
PNA (steric-blocking)
|
no |
|
|
yes |
yes |
|
EXP001343
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF14
|
plasmid DNA
|
no |
yes |
|
no |
no |
|
EXP001344
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF14
|
plasmid DNA
|
no |
yes |
|
no |
no |
|
EXP001345
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF14
|
plasmid DNA
|
no |
yes |
|
no |
no |
|
EXP001346
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF14
|
plasmid DNA
|
no |
yes |
|
no |
no |
|
EXP001347
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF14
|
plasmid DNA
|
no |
yes |
|
no |
no |
|
EXP001348
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF14
|
plasmid DNA
|
no |
yes |
|
no |
no |
|
EXP001349
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF221
|
plasmid DNA
|
no |
yes |
|
no |
no |
|
EXP001350
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF221
|
plasmid DNA
|
no |
yes |
|
no |
no |
|
EXP001351
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF221
|
plasmid DNA
|
no |
yes |
|
no |
no |
|
EXP001352
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF221
|
plasmid DNA
|
no |
yes |
|
no |
no |
|
EXP001353
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF221
|
plasmid DNA
|
no |
yes |
|
no |
no |
|
EXP001354
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF221
|
plasmid DNA
|
no |
yes |
|
no |
no |
|
EXP001355
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF14
|
splice-correction oligonucleotide (SCO/ASO)
|
yes |
yes |
|
no |
no |
|
EXP001356
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF14
|
splice-correction oligonucleotide (SCO/ASO)
|
yes |
yes |
|
no |
no |
|
EXP001357
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF14
|
splice-correction oligonucleotide (SCO/ASO)
|
yes |
yes |
|
no |
no |
|
EXP001358
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF14
|
splice-correction oligonucleotide (SCO/ASO)
|
yes |
yes |
|
no |
no |
|
EXP001359
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF14
|
splice-correction oligonucleotide (SCO/ASO)
|
yes |
yes |
|
no |
no |
|
EXP001360
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF14
|
splice-correction oligonucleotide (SCO/ASO)
|
yes |
yes |
|
no |
no |
|
EXP001361
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF221
|
splice-correction oligonucleotide (SCO/ASO)
|
no |
yes |
|
no |
no |
|
EXP001362
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF221
|
splice-correction oligonucleotide (SCO/ASO)
|
no |
yes |
|
no |
no |
|
EXP001363
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF221
|
splice-correction oligonucleotide (SCO/ASO)
|
no |
yes |
|
no |
no |
|
EXP001364
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF221
|
splice-correction oligonucleotide (SCO/ASO)
|
no |
yes |
|
no |
no |
|
EXP001365
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF221
|
splice-correction oligonucleotide (SCO/ASO)
|
no |
yes |
|
no |
no |
|
EXP001366
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF221
|
splice-correction oligonucleotide (SCO/ASO)
|
no |
yes |
|
no |
no |
|
EXP001367
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF14
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001368
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF14
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001369
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF14
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001370
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF14
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001371
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF14
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001372
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF14
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001373
|
Chitosan enhances gene delivery of oligonucleotide complexes with magnetic nano…
|
2018 |
PF14
|
plasmid DNA
|
no |
yes |
|
no |
no |
|
EXP001374
|
Chitosan enhances gene delivery of oligonucleotide complexes with magnetic nano…
|
2018 |
PF14
|
plasmid DNA
|
no |
yes |
|
no |
no |
|
EXP001375
|
Chitosan enhances gene delivery of oligonucleotide complexes with magnetic nano…
|
2018 |
PF221
|
plasmid DNA
|
no |
yes |
|
no |
no |
|
EXP001376
|
Chitosan enhances gene delivery of oligonucleotide complexes with magnetic nano…
|
2018 |
PF221
|
plasmid DNA
|
no |
yes |
|
no |
no |
|
EXP001377
|
Chitosan enhances gene delivery of oligonucleotide complexes with magnetic nano…
|
2018 |
PF14
|
antisense oligonucleotide
|
no |
yes |
|
no |
no |
|
EXP001378
|
Chitosan enhances gene delivery of oligonucleotide complexes with magnetic nano…
|
2018 |
PF14
|
antisense oligonucleotide
|
yes |
yes |
|
no |
no |
|
EXP001379
|
Chitosan enhances gene delivery of oligonucleotide complexes with magnetic nano…
|
2018 |
PF221
|
antisense oligonucleotide
|
no |
yes |
|
no |
no |
|
EXP001380
|
Chitosan enhances gene delivery of oligonucleotide complexes with magnetic nano…
|
2018 |
PF221
|
antisense oligonucleotide
|
no |
yes |
|
no |
no |
|
EXP001381
|
Chitosan enhances gene delivery of oligonucleotide complexes with magnetic nano…
|
2018 |
PF14
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001382
|
Chitosan enhances gene delivery of oligonucleotide complexes with magnetic nano…
|
2018 |
PF14
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001383
|
Chitosan enhances gene delivery of oligonucleotide complexes with magnetic nano…
|
2018 |
PF221
|
siRNA
|
no |
|
|
no |
no |
|
EXP001384
|
Vitamin B12 as a carrier of peptide nucleic acid (PNA) into bacterial cells
|
2017 |
(KFF)3K
|
PNA (antisense oligonucleotide)
|
no |
yes |
|
no |
no |
|
EXP001385
|
Vitamin B12 as a carrier of peptide nucleic acid (PNA) into bacterial cells
|
2017 |
(KFF)3K
|
PNA (antisense oligonucleotide)
|
no |
yes |
|
no |
no |
|
EXP001397
|
Therapeutic Effects on Atopic Dermatitis by Anti-RelA Short Interfering RNA Com…
|
2011 |
Tat analog (CPP) + AT1002 analog (TJ modulator)
|
siRNA
|
yes |
|
|
yes |
no |
|
EXP001398
|
Therapeutic Effects on Atopic Dermatitis by Anti-RelA Short Interfering RNA Com…
|
2011 |
Tat analog (CPP) + AT1002 analog (TJ modulator)
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP001399
|
Non-transgenic Gene Modulation via Spray Delivery of Nucleic Acid/Peptide Compl…
|
2022 |
KH9-BP100
|
siRNA
|
no |
|
|
yes |
yes |
|
EXP001400
|
Non-transgenic Gene Modulation via Spray Delivery of Nucleic Acid/Peptide Compl…
|
2022 |
KH9-BP100
|
siRNA
|
no |
|
|
yes |
yes |
|
EXP001401
|
Non-transgenic Gene Modulation via Spray Delivery of Nucleic Acid/Peptide Compl…
|
2022 |
KH9-OEP34 (CTP) + BP100 (CPP)
|
siRNA
|
no |
|
|
yes |
yes |
|
EXP001402
|
Non-transgenic Gene Modulation via Spray Delivery of Nucleic Acid/Peptide Compl…
|
2022 |
KH9-OEP34 (CTP) + BP100 (CPP)
|
siRNA
|
no |
|
|
yes |
yes |
|
EXP001403
|
Non-transgenic Gene Modulation via Spray Delivery of Nucleic Acid/Peptide Compl…
|
2022 |
KH9-OEP34 (CTP) + BP100 (CPP)
|
siRNA
|
no |
|
|
yes |
yes |
|
EXP001404
|
Cell penetrating peptide-mediated systemic siRNA delivery to the liver
|
2011 |
Octaarginine (R8)
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP001405
|
Cell penetrating peptide-mediated systemic siRNA delivery to the liver
|
2011 |
Octaarginine (R8)
|
siRNA
|
yes |
|
yes |
yes |
yes |
|
EXP001406
|
Solid formulation of cell-penetrating peptide nanocomplexes with siRNA and thei…
|
2012 |
PepFect 14 (PF14)
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001407
|
Solid formulation of cell-penetrating peptide nanocomplexes with siRNA and thei…
|
2012 |
PepFect 14 (PF14)
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001408
|
Solid formulation of cell-penetrating peptide nanocomplexes with siRNA and thei…
|
2012 |
PepFect 14 (PF14)
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001409
|
Solid formulation of cell-penetrating peptide nanocomplexes with siRNA and thei…
|
2012 |
PepFect 14 (PF14)
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001410
|
Solid formulation of cell-penetrating peptide nanocomplexes with siRNA and thei…
|
2012 |
PepFect 14 (PF14)
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001411
|
Solid formulation of cell-penetrating peptide nanocomplexes with siRNA and thei…
|
2012 |
PepFect 14 (PF14)
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001412
|
Calcium condensed cell penetrating peptide complexes offer highly efficient, lo…
|
2012 |
TAT
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001413
|
Calcium condensed cell penetrating peptide complexes offer highly efficient, lo…
|
2012 |
dTAT (double TAT)
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001414
|
Calcium condensed cell penetrating peptide complexes offer highly efficient, lo…
|
2012 |
dTAT (double TAT)
|
siRNA
|
no |
|
|
yes |
no |
|
EXP001415
|
Calcium condensed cell penetrating peptide complexes offer highly efficient, lo…
|
2012 |
dTAT (double TAT)
|
siRNA
|
no |
|
|
yes |
yes |
|
EXP001416
|
Mitochondrial transgene expression via an artificial mitochondrial DNA vector i…
|
2018 |
KALA
|
pDNA (plasmid DNA)
|
yes |
yes |
|
no |
no |
|
EXP001417
|
Mitochondrial transgene expression via an artificial mitochondrial DNA vector i…
|
2018 |
KALA
|
pDNA (plasmid DNA)
|
yes |
yes |
|
no |
no |
|
EXP001418
|
Mitochondrial transgene expression via an artificial mitochondrial DNA vector i…
|
2018 |
KALA
|
pDNA (plasmid DNA)
|
yes |
yes |
|
no |
no |
|
EXP001419
|
Mitochondrial transgene expression via an artificial mitochondrial DNA vector i…
|
2018 |
KALA
|
pDNA (plasmid DNA)
|
no |
|
|
yes |
no |
|
EXP001420
|
Mitochondrial transgene expression via an artificial mitochondrial DNA vector i…
|
2018 |
KALA
|
pDNA (plasmid DNA)
|
no |
|
|
yes |
no |
|
EXP001421
|
Cell-penetrating peptide-siRNA conjugate loaded YSA-modified nanobubbles for ul…
|
2015 |
Penetratin-derived CPP
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP001422
|
Cell-penetrating peptide-siRNA conjugate loaded YSA-modified nanobubbles for ul…
|
2015 |
Penetratin-derived CPP
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP001423
|
Cell-penetrating peptide-siRNA conjugate loaded YSA-modified nanobubbles for ul…
|
2015 |
Penetratin-derived CPP
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP001424
|
Cell-penetrating peptide-siRNA conjugate loaded YSA-modified nanobubbles for ul…
|
2015 |
Penetratin-derived CPP
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP001425
|
Cell-penetrating peptide-siRNA conjugate loaded YSA-modified nanobubbles for ul…
|
2015 |
Penetratin-derived CPP
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP001426
|
Cell-penetrating peptide-siRNA conjugate loaded YSA-modified nanobubbles for ul…
|
2015 |
Penetratin-derived CPP
|
siRNA
|
yes |
|
|
yes |
no |
|
EXP001427
|
Cell-penetrating peptide-siRNA conjugate loaded YSA-modified nanobubbles for ul…
|
2015 |
Penetratin-derived CPP
|
siRNA
|
yes |
|
|
yes |
no |
|
EXP001428
|
Tetrahedral DNA Nanoparticle Vector for Intracellular Delivery of Targeted Pept…
|
2017 |
N/A (DNA tetrahedron vector; no peptide carrier)
|
PNA (antisense oligonucleotide)
|
no |
yes |
|
no |
no |
|
EXP001430
|
A novel cell-penetrating peptide TAT-A1 delivers siRNA into tumor cells selecti…
|
2013 |
TAT-A1 (VEGFR1-targeted TAT)
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP001431
|
A novel cell-penetrating peptide TAT-A1 delivers siRNA into tumor cells selecti…
|
2013 |
TAT-A1 (VEGFR1-targeted TAT)
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP001432
|
A novel cell-penetrating peptide TAT-A1 delivers siRNA into tumor cells selecti…
|
2013 |
TAT (HIV-1 Tat CPP)
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP001433
|
A novel cell-penetrating peptide TAT-A1 delivers siRNA into tumor cells selecti…
|
2013 |
TAT (HIV-1 Tat CPP)
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP001434
|
Improving the efficacy of liposome-mediated vascular gene therapy via lipid sur…
|
2017 |
Octaarginine (R8)
|
siRNA
|
yes |
|
|
no |
no |
|
EXP001435
|
Improving the efficacy of liposome-mediated vascular gene therapy via lipid sur…
|
2017 |
Octaarginine (R8)
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP001437
|
Safer and efficient base editing and prime editing via ribonucleoproteins deliv…
|
2025 |
TAT-ABE8e (covalent CPP fusion)
|
Guide RNA (sgRNA/epegRNA)
|
no |
yes |
|
no |
no |
|
EXP001438
|
Safer and efficient base editing and prime editing via ribonucleoproteins deliv…
|
2025 |
CPP5-ABE8e (covalent CPP fusion)
|
Guide RNA (sgRNA/epegRNA)
|
no |
yes |
|
no |
no |
|
EXP001439
|
Safer and efficient base editing and prime editing via ribonucleoproteins deliv…
|
2025 |
ANTP-ABE8e (covalent CPP fusion)
|
Guide RNA (sgRNA/epegRNA)
|
no |
yes |
|
no |
no |
|
EXP001442
|
Safer and efficient base editing and prime editing via ribonucleoproteins deliv…
|
2025 |
CPP5-ABE8e (covalent CPP fusion)
|
Guide RNA (sgRNA/epegRNA)
|
no |
|
|
yes |
yes |
|
EXP001443
|
Safer and efficient base editing and prime editing via ribonucleoproteins deliv…
|
2025 |
TAT-ABE8e (covalent CPP fusion)
|
Guide RNA (sgRNA/epegRNA)
|
no |
|
|
yes |
yes |
|
EXP001444
|
Safer and efficient base editing and prime editing via ribonucleoproteins deliv…
|
2025 |
ANTP-ABE8e (covalent CPP fusion)
|
Guide RNA (sgRNA/epegRNA)
|
no |
|
|
yes |
yes |
|
EXP001445
|
Super-resolution Imaging of Structure, Molecular Composition, and Stability of …
|
2019 |
L-nona-arginine (R9)
|
mRNA
|
yes |
no |
|
no |
no |
|
EXP001446
|
Super-resolution Imaging of Structure, Molecular Composition, and Stability of …
|
2019 |
L-nona-arginine (R9)
|
mRNA
|
yes |
no |
|
no |
no |
|
EXP001447
|
Super-resolution Imaging of Structure, Molecular Composition, and Stability of …
|
2019 |
L-nona-arginine (R9)
|
mRNA
|
yes |
no |
|
no |
no |
|
EXP001448
|
Super-resolution Imaging of Structure, Molecular Composition, and Stability of …
|
2019 |
L-nona-arginine (R9)
|
mRNA
|
yes |
no |
|
no |
no |
|
EXP001449
|
Iron oxide nanoparticles decorated with functional peptides for a targeted siRN…
|
2022 |
CTX-R10 (chlorotoxin + deca-arginine)
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP001450
|
Iron oxide nanoparticles decorated with functional peptides for a targeted siRN…
|
2022 |
CTX-R10 (chlorotoxin + deca-arginine)
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP001452
|
Chaperonin–Dendrimer Conjugates for siRNA Delivery
|
2016 |
TAT
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP001453
|
Human DMBT1-Derived Cell-Penetrating Peptides for Intracellular siRNA Delivery
|
2017 |
SRCRP2-11 (DMBT1-derived CPP)
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP001454
|
Human DMBT1-Derived Cell-Penetrating Peptides for Intracellular siRNA Delivery
|
2017 |
SRCRP2-11-R (DMBT1-derived CPP mutant)
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP001455
|
Human DMBT1-Derived Cell-Penetrating Peptides for Intracellular siRNA Delivery
|
2017 |
TAT (control CPP)
|
siRNA
|
yes |
yes |
|
no |
no |